Related Experiment Video
Updated: Mar 9, 2026

Hepatocyte-specific Ablation in Zebrafish to Study Biliary-driven Liver Regeneration
Published on: May 20, 2015
RYBP Expression Is Regulated by KLF4 and Sp1 and Is Related to Hepatocellular Carcinoma Prognosis
Qiaojiajie Zhao1, Weihua Cai2, Xuan Zhang1
1From the State Key Laboratory of Medical Molecular Biology, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, 5 Dong Dan San Tiao, Beijing 100005, China.
Abstract:
The expression of Ring1- and YY1-binding protein (RYBP) is reduced in several human cancers, but the molecular mechanism(s) have remained elusive. In this study, we used human hepatocellular carcinoma (HCC) cell lines and tissue specimens to study the mechanism and herein report several new findings. First, we cloned and characterized the basal promoter region of the human RYBP gene. We found that the decreased RYBP expression in HCC tissues was not due to promoter sequence variation/polymorphisms or CpG dinucleotide methylation. We identified two transcription factors, KLF4 and Sp1, which directly bind the promoter region of RYBP to induce and suppress RYBP transcription, respectively. We mapped the binding sites of KLF4 and Sp1 on the RYBP promoter. Studies in vitro showed that KLF4 suppresses whereas Sp1 promotes HCC cell growth through modulating RYBP expression. Deregulated KLF4 and Sp1 contributed to decreased expression of RYBP in HCC tumor tissues. Our studies of human HCC tissues indicated that a diminished RYBP level in the tumor (in association with altered KLF4 and Sp1 expression) was statistically associated with a larger tumor size, poorer differentiation, and an increased susceptibility to distant metastasis. These findings help to clarify why RYBP is decreased in HCC and indicate that deregulated KLF4, Sp1, and RYBP may lead to a poorer prognosis. Our findings support the idea that RYBP may represent a target for cancer therapy and suggest that it may be useful as a prognostic biomarker for HCC, either alone or in combination with KLF4 and Sp1.
Insights
Reduced Ring1- and YY1-binding protein (RYBP) in hepatocellular carcinoma (HCC) is linked to KLF4 and Sp1 transcription factors. Altered expression of these factors and RYBP correlates with poorer HCC prognosis and metastasis.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Ring1- and YY1-binding protein (RYBP) expression is decreased in human cancers, but the underlying mechanisms are unclear.
- Hepatocellular carcinoma (HCC) is a major global health concern with complex molecular underpinnings.
- Understanding the regulation of RYBP is crucial for developing novel cancer therapies and biomarkers.
Purpose of the Study:
- To elucidate the molecular mechanisms regulating RYBP expression in HCC.
- To identify transcription factors involved in RYBP dysregulation in HCC.
- To investigate the correlation between RYBP, KLF4, Sp1, and HCC patient prognosis.
Main Methods:
- Cloning and characterization of the human RYBP gene promoter region.
- Analysis of promoter sequence variation and CpG methylation in HCC tissues.
- Identification and mapping of transcription factor binding sites (KLF4 and Sp1) on the RYBP promoter.
- In vitro studies on HCC cell growth modulation by KLF4 and Sp1.
- Correlation analysis of RYBP, KLF4, and Sp1 expression with clinical parameters in HCC patient specimens.
Main Results:
- Decreased RYBP expression in HCC is not due to promoter mutations or methylation.
- KLF4 suppresses and Sp1 promotes RYBP transcription by binding to its promoter.
- KLF4 inhibits and Sp1 promotes HCC cell growth via RYBP modulation.
- Deregulated KLF4 and Sp1 contribute to reduced RYBP levels in HCC tumors.
- Lower RYBP levels, associated with altered KLF4/Sp1, correlate with larger tumor size, poorer differentiation, and increased metastasis.
Conclusions:
- KLF4 and Sp1 are key regulators of RYBP expression in HCC.
- Dysregulation of KLF4, Sp1, and RYBP is associated with poor HCC prognosis and metastasis.
- RYBP may serve as a potential therapeutic target and prognostic biomarker for HCC, possibly in combination with KLF4 and Sp1.
More Related Videos
07:09Hepatic Progenitor Specification from Pluripotent Stem Cells using a Defined Differentiation System
Published on: May 10, 2020
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Related Concept Videos
Cell Specific Gene Expression
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Abnormal Proliferation